Bayer/GSK vardenafil
Executive Summary
Trade name for erectile dysfunction disorder drug vardenafil is Levitra, Bayer and GlaxoSmithKline announce. Bayer had earlier referred to the drug as Nuviva; the name was one of several submitted to FDA for approval (1"The Pink Sheet" March 18, p. 29). The companies received an "approvable" letter for vardenafil in July; approval is expected in 2003 (2"The Pink Sheet" July 29, In Brief)...
You may also be interested in...
Analysts Presentations, Conference Calls In Brief
Bayer's vardenafil is Nuviva: Bayer's brand name for vardenafil is Nuviva, R&D Board Committee Chair Frank Morich, PhD, announced during a press briefing March 13. An NDA for the erectile dysfunction drug is pending at FDA; Bayer expects approval in the second half of 2002. Nuviva will be co-promoted with GlaxoSmithKline...
Prescience Point Capital Launches Proxy Fight To Change MiMedx's Board
Prescience Point Capital is trying to reshuffle the board of directors leading regenerative medicine company MiMedx, arguing the company’s current board has destroyed shareholder value. The company's tock is selling for about a third of its potential value, according to Prescience.
In Flood Of 2020 Sanitizer Launches, Unilever’s Suave Brand Tops US Category Sales
Unilever’s Suave brand led new sanitizer product sales in 2020, when hand sanitizers total sales grew 569%, according to IRI. Sales of rinseable hand-soap sales grew 64% and antiseptics 19%.